Biologics are large-molecule medications created in a lab from ... They are a common form of treatment used in ulcerative ...

Proctitis affects the rectum, whereas ulcerative colitis can affect the colon ... who can prescribe medication and strategies to better manage the condition. Other drugs that doctors prescribe ...

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...

Omvoh is now approved in the U.S. for two types of inflammatory bowel disease (IBD), following its October 2023 approval as a first-in-class treatment for moderately to severely active ulcerative ...

Ulcerative Colitis companies are Janssen Pharmaceuticals, Takeda Pharmaceuticals, Pfizer, EA Pharma, Kissei Pharma, Gilead Sciences, Galapagos NV, Celgene (Bristol-Myers Squibb), AbbVie ...

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...

The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.

FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease On Wednesday, the FDA approved Eli Lilly And Co’s (NYSE:LLY) Omvoh (mirikizumab-mrkz) for moderately to ...

Omvoh demonstrated 53% clinical remission and 46% endoscopic response in Crohn's patients after one year, outperforming placebo. Over 80% of patients maintained endoscopic response after two years ...